Medicare Enrolled
Dr. Deric Savior, M.D.
Medical Oncology · Wynnewood, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Savior from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Savior?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Savior
Dr. Deric Savior is a medical oncology specialist in Wynnewood, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Savior performed 37,964 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Savior received a total of $292,437 from 81 pharmaceutical and/or device companies across 682 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Savior is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 4% volume in PA
$292,437 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗37,964
Medicare services
Top 4% in PA for medical oncology
Not available
Unique patients (not deduplicated)
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
36,000 | $1 | $4 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
674 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 500 | $1 | $122 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
272 | $104 | $224 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
109 | $110 | $686 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
84 | $24 | $152 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
82 | $74 | $148 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
71 | $53 | $304 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
57 | $13 | $105 |
| New patient office visit, complex (60-74 min) | 39 | $185 | $432 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
34 | $11 | $93 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
29 | $145 | $416 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $140 | $343 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
95.5% high complexity
3.3% medium
1.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$292,437
Total received (2018-2024)
Avg $41,777/year across 7 years
Top 2% in PA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
81
Companies
682
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$51,672
2023
$51,767
2022
$36,555
2021
$67,665
2020
$29,305
2019
$37,036
2018
$18,437
Payments by company (2024)
Regeneron Healthcare Solutions, Inc.
$24,033
JAZZ PHARMACEUTICALS INC.
$8,612
Janssen Biotech, Inc.
$5,423
Regeneron Pharmaceuticals, Inc.
$3,837
Fosun Pharma USA Inc.
$3,820
Bayer Healthcare Pharmaceuticals Inc.
$1,782
AstraZeneca Pharmaceuticals LP
$548
Novartis Pharmaceuticals Corporation
$318
Genentech USA, Inc.
$245
Dendreon Pharmaceuticals LLC
$224
Merck Sharp & Dohme LLC
$199
Astellas Pharma US Inc
$196
Eisai Inc.
$178
PFIZER INC.
$158
Lilly USA, LLC
$156
Alexion Pharmaceuticals, Inc.
$140
Incyte Corporation
$125
Takeda Pharmaceuticals U.S.A., Inc.
$124
Daiichi Sankyo Inc.
$119
E.R. Squibb & Sons, L.L.C.
$118
Gilead Sciences, Inc.
$113
Ipsen Biopharmaceuticals, Inc
$85
GENZYME CORPORATION
$81
GlaxoSmithKline, LLC.
$77
Celgene Corporation
$66
Tempus AI, Inc
$61
ABBVIE INC.
$58
SOBI, INC
$55
EMD Serono, Inc.
$51
BeiGene USA, Inc.
$50
Blueprint Medicines Corporation
$46
Stemline Therapeutics Inc.
$43
TerSera Therapeutics LLC
$42
PUMA BIOTECHNOLOGY, INC.
$41
Genmab U.S., Inc.
$40
ARRAY BIOPHARMA INC
$39
Immunocore Limited
$38
Exelixis Inc.
$34
Cumberland Pharmaceuticals, Inc.
$33
ImmunoGen, Inc.
$30
Karyopharm Therapeutics Inc.
$25
Deciphera Pharmaceuticals Inc.
$24
Fennec Pharmaceuticals, Inc.
$23
Novocure Inc.
$23
Amgen Inc.
$22
Rigel Pharmaceuticals, Inc.
$21
Aveo Pharmaceuticals, Inc.
$20
Acrotech Biopharma Inc.
$19
Sumitomo Pharma America, Inc.
$16
Pharmacosmos Therapeutics Inc.
$15
Secura Bio, Inc.
$15
Coherus Biosciences Inc.
$14
Top 3 companies account for 73.7% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$99,394
GENZYME CORPORATION
$68,128
JAZZ PHARMACEUTICALS INC.
$42,305
Celgene Corporation
$23,298
Jazz Pharmaceuticals Inc.
$11,570
Merck Sharp & Dohme Corporation
$6,667
Janssen Biotech, Inc.
$5,700
E.R. Squibb & Sons, L.L.C.
$4,579
Regeneron Pharmaceuticals, Inc.
$3,987
Genentech USA, Inc.
$3,844
Fosun Pharma USA Inc.
$3,820
AstraZeneca Pharmaceuticals LP
$3,150
Eli Lilly and Company
$2,925
Blueprint Medicines Corporation
$2,123
Takeda Pharmaceuticals U.S.A., Inc.
$1,900
Bayer Healthcare Pharmaceuticals Inc.
$1,886
Novartis Pharmaceuticals Corporation
$709
Astellas Pharma US Inc
$541
Seagen Inc.
$541
Lilly USA, LLC
$534
Merck Sharp & Dohme LLC
$476
Eisai Inc.
$322
PFIZER INC.
$269
GlaxoSmithKline, LLC.
$253
Daiichi Sankyo Inc.
$231
Dendreon Pharmaceuticals LLC
$224
Incyte Corporation
$207
Alexion Pharmaceuticals, Inc.
$184
Gilead Sciences, Inc.
$182
Ipsen Biopharmaceuticals, Inc
$179
Exelixis Inc.
$140
Karyopharm Therapeutics Inc.
$90
Amgen Inc.
$90
Genmab U.S., Inc.
$81
Mirati Therapeutics, Inc.
$79
MorphoSys, US Inc.
$75
Kite Pharma, Inc.
$71
SANOFI-AVENTIS U.S. LLC
$70
BeiGene USA, Inc.
$70
PharmaEssentia USA Corporation
$65
Stemline Therapeutics Inc.
$65
ARRAY BIOPHARMA INC
$62
Tempus AI, Inc
$61
TerSera Therapeutics LLC
$60
ImmunoGen, Inc.
$60
PUMA BIOTECHNOLOGY, INC.
$60
ABBVIE INC.
$58
Pharmacosmos Therapeutics Inc.
$56
SOBI, INC
$55
Rigel Pharmaceuticals, Inc.
$54
Deciphera Pharmaceuticals Inc.
$51
EMD Serono, Inc.
$51
Taiho Oncology, Inc.
$46
Apellis Pharmaceuticals, Inc.
$45
Acrotech Biopharma LLC
$40
Acrotech Biopharma Inc.
$39
Immunocore Limited
$38
Boehringer Ingelheim Pharmaceuticals, Inc.
$37
Cumberland Pharmaceuticals, Inc.
$33
Puma Biotechnology, Inc.
$33
Adaptive Biotechnologies Corporation
$33
Sumitomo Pharma America, Inc.
$32
Organon LLC
$32
EISAI INC.
$32
Alnylam Pharmaceuticals Inc.
$29
Heron Therapeutics, Inc.
$27
Foundation Medicine, Inc.
$26
Biogen, Inc.
$24
G1 Therapeutics, Inc.
$24
Fennec Pharmaceuticals, Inc.
$23
Novocure Inc.
$23
Aveo Pharmaceuticals, Inc.
$20
Fresenius Kabi USA, LLC
$20
Myovant Sciences Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$19
AVEO Pharmaceuticals, Inc.
$18
TAIHO ONCOLOGY, INC.
$17
Epizyme, Inc.,
$16
Secura Bio, Inc.
$15
Coherus Biosciences Inc.
$14
Global Blood Therapeutics, Inc.
$13
Top 3 companies account for 71.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CINVANTI · COPIKTRA · COSELA · CYRAMZA · DARZALEX · DOPTELET · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Elahere · Empaveli · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Itovebi · JAKAFI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nplate · Nubeqa · OJJAARA · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Pedmark · Polivy · Pomalyst · QINLOCK · Quzyttir · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SYNAGIS · Serplulimab · Somatuline Depot · Stimufend · Stivarga · TAGRISSO · TALVEY · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TUKYSA · Tarceva · Tavalisse · Tivdak · Trodelvy · ULTOMIRIS · Udenyca · VERZENIO · Vanflyta · Vectibix · Venclexta · Vitrakvi · XPOVIO · XT CDX · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
120
County median income
$111,521
Nearest hospital to ZIP centroid (approximate)
MAIN LINE HOSPITAL LANKENAU
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Savior is a mixed practice specialist, with above-average Medicare volume (top 4% in PA), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Savior experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Savior performed 36,000 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Savior receive payments from pharmaceutical companies?
Yes. Dr. Savior received a total of $292,437 from 81 companies across 682 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Savior's costs compare to other medical oncologists in Wynnewood?
Dr. Savior's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Savior) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Wynnewood
Browse medical oncologists in Wynnewood ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in PA
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in PA
Which PA medical oncologists receive the most from drug and device companies.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
JAZZ PHARMACEUTICALS INC. Payments to Doctors
See all physicians who received payments from JAZZ PHARMACEUTICALS INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology